Loading…
BridgeBio Pharma is a biopharmaceutical company focused on developing transformative medicines for patients with genetic diseases. The company employs a novel approach that integrates finance and science to accelerate the discovery and development of treatments for underserved patient populations.
AI named BridgeBio from December 2025 to February 2026.